446 related articles for article (PubMed ID: 17403913)
1. Effect of arylamine acetyltransferase Nat3 gene knockout on N-acetylation in the mouse.
Sugamori KS; Brenneman D; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM
Drug Metab Dispos; 2007 Jul; 35(7):1064-70. PubMed ID: 17403913
[TBL] [Abstract][Full Text] [Related]
2. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.
Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW
Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359
[TBL] [Abstract][Full Text] [Related]
3. Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice.
Sugamori KS; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM
Mol Pharmacol; 2003 Jul; 64(1):170-9. PubMed ID: 12815173
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro metabolism of arylamine procarcinogens in acetyltransferase-deficient mice.
Sugamori KS; Brenneman D; Grant DM
Drug Metab Dispos; 2006 Oct; 34(10):1697-702. PubMed ID: 16815960
[TBL] [Abstract][Full Text] [Related]
5. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
Grant DM; Blum M; Beer M; Meyer UA
Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
[TBL] [Abstract][Full Text] [Related]
6. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of functional rat arylamine N-acetyltransferase 3: comparisons with rat arylamine N-acetyltransferases 1 and 2.
Walraven JM; Doll MA; Hein DW
J Pharmacol Exp Ther; 2006 Oct; 319(1):369-75. PubMed ID: 16829624
[TBL] [Abstract][Full Text] [Related]
8. Liver-selective expression of human arylamine N-acetyltransferase NAT2 in transgenic mice.
Sugamori KS; Brenneman D; Grant DM
Drug Metab Dispos; 2011 May; 39(5):882-90. PubMed ID: 21317369
[TBL] [Abstract][Full Text] [Related]
9. Neonatal ontogeny of murine arylamine N-acetyltransferases: implications for arylamine genotoxicity.
McQueen CA; Chau B
Toxicol Sci; 2003 Jun; 73(2):279-86. PubMed ID: 12700401
[TBL] [Abstract][Full Text] [Related]
10. Substrate selectivity of mouse N-acetyltransferases 1, 2, and 3 expressed in COS-1 cells.
Estrada-Rodgers L; Levy GN; Weber WW
Drug Metab Dispos; 1998 May; 26(5):502-5. PubMed ID: 9571233
[TBL] [Abstract][Full Text] [Related]
11. Arylamine N-acetyltransferases: structural and functional implications of polymorphisms.
Sim E; Lack N; Wang CJ; Long H; Westwood I; Fullam E; Kawamura A
Toxicology; 2008 Dec; 254(3):170-83. PubMed ID: 18852012
[TBL] [Abstract][Full Text] [Related]
12. Arylamine N-acetyltransferases: characterization of the substrate specificities and molecular interactions of environmental arylamines with human NAT1 and NAT2.
Liu L; Von Vett A; Zhang N; Walters KJ; Wagner CR; Hanna PE
Chem Res Toxicol; 2007 Sep; 20(9):1300-8. PubMed ID: 17672512
[TBL] [Abstract][Full Text] [Related]
13. N-acetyltransferase (Nat) 1 and 2 expression in Nat2 knockout mice.
Loehle JA; Cornish V; Wakefield L; Doll MA; Neale JR; Zang Y; Sim E; Hein DW
J Pharmacol Exp Ther; 2006 Nov; 319(2):724-8. PubMed ID: 16857729
[TBL] [Abstract][Full Text] [Related]
14. 4-Aminobiphenyl downregulation of NAT2 acetylator genotype-dependent N- and O-acetylation of aromatic and heterocyclic amine carcinogens in primary mammary epithelial cell cultures from rapid and slow acetylator rats.
Jefferson FA; Xiao GH; Hein DW
Toxicol Sci; 2009 Jan; 107(1):293-7. PubMed ID: 18842621
[TBL] [Abstract][Full Text] [Related]
15. Construction of Syrian hamster lines congenic at the polymorphic acetyltransferase locus (NAT2): acetylator genotype-dependent N- and O-acetylation of arylamine carcinogens.
Hein DW; Doll MA; Rustan TD; Gray K; Ferguson RJ; Feng Y
Toxicol Appl Pharmacol; 1994 Jan; 124(1):16-24. PubMed ID: 8291057
[TBL] [Abstract][Full Text] [Related]
16. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
[TBL] [Abstract][Full Text] [Related]
17. Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines.
Liu L; Wagner CR; Hanna PE
Chem Res Toxicol; 2009 Dec; 22(12):1962-74. PubMed ID: 19842618
[TBL] [Abstract][Full Text] [Related]
18. Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding.
Laurieri N; Kawamura A; Westwood IM; Varney A; Morris E; Russell AJ; Stanley LA; Sim E
BMC Pharmacol Toxicol; 2014 Nov; 15():68. PubMed ID: 25432241
[TBL] [Abstract][Full Text] [Related]
19. N-acetyltransferase expression and metabolic activation of the food-derived heterocyclic amines in the human mammary gland.
Sadrieh N; Davis CD; Snyderwine EG
Cancer Res; 1996 Jun; 56(12):2683-7. PubMed ID: 8665493
[TBL] [Abstract][Full Text] [Related]
20. Human N-acetylation of benzidine: role of NAT1 and NAT2.
Zenser TV; Lakshmi VM; Rustan TD; Doll MA; Deitz AC; Davis BB; Hein DW
Cancer Res; 1996 Sep; 56(17):3941-7. PubMed ID: 8752161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]